ETF Holdings Breakdown of ZLAB

Stock NameZai Lab Ltd
TickerZLAB(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS98887Q1040
LEI549300P2UYQ9U5LY1T58

News associated with ZLAB

Hsbc Holdings PLC Purchases New Holdings in Zai Lab Limited (NASDAQ:ZLAB)
Hsbc Holdings PLC acquired a new position in Zai Lab Limited (NASDAQ:ZLAB – Free Report) during the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 18,840 shares of the company’s stock, valued at approximately $493,000. Several other institutional investors have also added to or reduced their stakes in ZLAB. Geode Capital Management LLC raised […] - 2025-05-07 07:56:55
Envestnet Asset Management Inc. Invests $976,000 in Zai Lab Limited (NASDAQ:ZLAB)
Envestnet Asset Management Inc. bought a new position in shares of Zai Lab Limited (NASDAQ:ZLAB – Free Report) during the fourth quarter, Holdings Channel reports. The fund bought 37,278 shares of the company’s stock, valued at approximately $976,000. Several other hedge funds have also made changes to their positions in ZLAB. Pictet Asset Management Holding […] - 2025-05-02 07:15:08
Wells Fargo & Company MN Acquires 40,454 Shares of Zai Lab Limited (NASDAQ:ZLAB)
Wells Fargo & Company MN boosted its holdings in shares of Zai Lab Limited (NASDAQ:ZLAB – Free Report) by 8,090.8% in the fourth quarter, HoldingsChannel reports. The fund owned 40,954 shares of the company’s stock after acquiring an additional 40,454 shares during the period. Wells Fargo & Company MN’s holdings in Zai Lab were worth […] - 2025-04-30 07:41:02
Bank of Montreal Can Has $442,000 Stock Position in Zai Lab Limited (NASDAQ:ZLAB)
Bank of Montreal Can boosted its position in shares of Zai Lab Limited (NASDAQ:ZLAB – Free Report) by 21.5% in the 4th quarter, HoldingsChannel.com reports. The firm owned 16,893 shares of the company’s stock after buying an additional 2,993 shares during the quarter. Bank of Montreal Can’s holdings in Zai Lab were worth $442,000 at […] - 2025-04-23 07:56:51
Zai Lab Limited (NASDAQ:ZLAB) Shares Purchased by Fmr LLC
Fmr LLC raised its position in Zai Lab Limited (NASDAQ:ZLAB – Free Report) by 749.1% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 5,475,505 shares of the company’s stock after purchasing an additional 4,830,646 shares during the period. Fmr LLC owned about 5.00% of Zai Lab worth […] - 2025-04-14 09:28:49
Russell Investments Group Ltd. Sells 25,938 Shares of Zai Lab Limited (NASDAQ:ZLAB)
Russell Investments Group Ltd. lessened its position in shares of Zai Lab Limited (NASDAQ:ZLAB – Free Report) by 10.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 231,694 shares of the company’s stock after selling 25,938 shares during the quarter. Russell Investments […] - 2025-04-14 07:54:58
Zai Lab (NASDAQ:ZLAB) Trading Down 7.1% After Insider Selling
Shares of Zai Lab Limited (NASDAQ:ZLAB – Get Free Report) were down 7.1% on Wednesday following insider selling activity. The stock traded as low as $24.74 and last traded at $25.14. Approximately 710,767 shares changed hands during mid-day trading, a decline of 26% from the average daily volume of 966,621 shares. The stock had previously […] - 2025-04-11 05:16:49
63,909 Shares in Zai Lab Limited (NASDAQ:ZLAB) Acquired by Zurcher Kantonalbank Zurich Cantonalbank
Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in shares of Zai Lab Limited (NASDAQ:ZLAB – Free Report) during the fourth quarter, HoldingsChannel reports. The firm purchased 63,909 shares of the company’s stock, valued at approximately $1,674,000. Other institutional investors have also added to or reduced their stakes in the company. Principal Financial Group Inc. […] - 2025-03-18 08:54:52
Cantor Fitzgerald Upgrades Zai Lab (NASDAQ:ZLAB) to “Strong-Buy”
Cantor Fitzgerald upgraded shares of Zai Lab (NASDAQ:ZLAB – Free Report) to a strong-buy rating in a report released on Tuesday,Zacks.com reports. Cantor Fitzgerald also issued estimates for Zai Lab’s FY2025 earnings at ($1.38) EPS. Separately, Bank of America reissued a “neutral” rating and set a $36.10 price objective (up from $29.00) on shares of […] - 2025-03-07 06:30:47
Bank of America Reiterates Neutral Rating for Zai Lab (NASDAQ:ZLAB)
Zai Lab (NASDAQ:ZLAB – Get Free Report)‘s stock had its “neutral” rating reiterated by research analysts at Bank of America in a note issued to investors on Monday, MarketBeat reports. They presently have a $36.10 price objective on the stock, up from their previous price objective of $29.00. Bank of America‘s target price would suggest […] - 2025-03-05 06:33:01
Principal Financial Group Inc. Invests $46.17 Million in Zai Lab Limited (NASDAQ:ZLAB)
Principal Financial Group Inc. acquired a new position in Zai Lab Limited (NASDAQ:ZLAB – Free Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 1,762,954 shares of the company’s stock, valued at approximately $46,172,000. A number of other institutional investors and hedge funds have also modified their holdings of ZLAB. Y Intercept […] - 2025-02-21 09:49:08
Zai Lab (NASDAQ:ZLAB) Stock Rating Upgraded by Cantor Fitzgerald
Zai Lab (NASDAQ:ZLAB – Get Free Report) was upgraded by stock analysts at Cantor Fitzgerald to a “strong-buy” rating in a report issued on Wednesday,Zacks.com reports. Separately, JPMorgan Chase & Co. increased their price target on Zai Lab from $38.00 to $44.00 and gave the stock an “overweight” rating in a research report on Monday, […] - 2025-02-07 06:28:44

ZLAB institutional holdings

The following institutional investment holdings of ZLAB have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 29,309USD 854,064
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 29,309USD 854,064 2.7%
Total =58,618 USD 1,708,128
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.